“…This process allows the study of CNS-derived miRNA fingerprints through a simple collection of accessible material, for example, blood or even saliva (Grasso et al, 2014;. Expression profiling of extracellular miRNAs as putative biomarkers for various CNS disorders has already been reported in studies focused on epilepsy (An et al, 2016;De Matteis et al, 2018;Wang et al, 2015a), Parkinson's disease (Chen et al, 2018), bipolar mania (Rong et al, 2011), depressive disorders (Wang et al, 2015b), vascular dementia (Ragusa et al, 2016), attention-deficit/hyperactivity disorder (Wu et al, 2015), schizophrenia (Vachev et al, 2016;Wei et al, 2015), Tourette syndrome (Rizzo et al, 2015), ASD (Cirnigliaro et al, 2017;Kichukova et al, 2017;Mundalil Vasu et al, 2014), posttraumatic stress (Balakathiresan et al, 2014), and even internet gaming disorder (Lee et al, 2018). Particularly for ASD, dysregulated miRNAs have been detected in samples from different origin such as brain cortex and cerebellum (Ander et al, 2015;Schumann et al, 2017), peripheral blood (Huang et al, 2015), serum (Kichukova et al, 2017;Mundalil Vasu et al, 2014), saliva , olfactory mucosal stem cells (Nguyen et al, 2016), monocytes (Jyonouchi et al, 2017), and lymphoblastoid cell lines (Sarachana et al, 2010).…”